Literature DB >> 35314142

Single-molecule phospholipase A2 becomes processive on melittin-induced membrane deformations.

Tyler A Jepson1, Sarah C Hall1, Jean K Chung2.   

Abstract

While it is established that the topology of lipid membranes plays an important role in biochemical processes, few direct observations exist regarding how the membranes are actively restructured and its consequences on subsequent reactions. In this work, we investigated how the two major components of bee venom, melittin and phospholipase A2 (PLA2), achieve activation by such membrane remodeling. Their membrane-disrupting functions have been reported to increase when both are present, but the mechanism of this synergism had not been established. Using membrane reconstitution, we found that melittin can form large-scale membrane deformities upon which PLA2 activity is 25-fold higher. Tracking of single-molecule PLA2 revealed that its processive behavior on these deformities underlies the enhanced activity. These results show how melittin and PLA2 work synergistically to enhance the lytic effects of the bee venom. More broadly, they also demonstrate how the membrane topology may be actively altered to modulate cellular membrane-bound reactions.
Copyright © 2022 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35314142      PMCID: PMC9072580          DOI: 10.1016/j.bpj.2022.03.019

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   3.699


  45 in total

1.  On the mechanism of pore formation by melittin.

Authors:  Geert van den Bogaart; Jeanette Velásquez Guzmán; Jacek T Mika; Bert Poolman
Journal:  J Biol Chem       Date:  2008-09-25       Impact factor: 5.157

Review 2.  The actions of melittin on membranes.

Authors:  C E Dempsey
Journal:  Biochim Biophys Acta       Date:  1990-05-07

3.  Enhancement of bee venom phospholipase A2 activity by melittin, direct lytic factor from cobra venom and polymyxin B.

Authors:  C Mollay; G Kreil
Journal:  FEBS Lett       Date:  1974-09-15       Impact factor: 4.124

4.  DHA-induced changes of supported lipid membrane morphology.

Authors:  Dorota Thid; Jason J Benkoski; Sofia Svedhem; Bengt Kasemo; Julie Gold
Journal:  Langmuir       Date:  2007-04-25       Impact factor: 3.882

Review 5.  Melittin: a lytic peptide with anticancer properties.

Authors:  Goran Gajski; Vera Garaj-Vrhovac
Journal:  Environ Toxicol Pharmacol       Date:  2013-06-28       Impact factor: 4.860

6.  Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway.

Authors:  Shujing Liu; Mei Yu; Ying He; Lin Xiao; Fang Wang; Changcheng Song; Shuhan Sun; Changquan Ling; Zhiheng Xu
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

Review 7.  Molecular mechanisms in signal transduction at the membrane.

Authors:  Jay T Groves; John Kuriyan
Journal:  Nat Struct Mol Biol       Date:  2010-05-23       Impact factor: 15.369

8.  The Cytotoxic Effect of Apis mellifera Venom with a Synergistic Potential of Its Two Main Components-Melittin and PLA2-On Colon Cancer HCT116 Cell Lines.

Authors:  Carole Yaacoub; Mariam Rifi; Dany El-Obeid; Hiba Mawlawi; Jean-Marc Sabatier; Bruno Coutard; Ziad Fajloun
Journal:  Molecules       Date:  2021-04-14       Impact factor: 4.411

9.  Molecular kinetics. Ras activation by SOS: allosteric regulation by altered fluctuation dynamics.

Authors:  Lars Iversen; Hsiung-Lin Tu; Wan-Chen Lin; Sune M Christensen; Steven M Abel; Jeff Iwig; Hung-Jen Wu; Jodi Gureasko; Christopher Rhodes; Rebecca S Petit; Scott D Hansen; Peter Thill; Cheng-Han Yu; Dimitrios Stamou; Arup K Chakraborty; John Kuriyan; Jay T Groves
Journal:  Science       Date:  2014-07-04       Impact factor: 47.728

10.  Snake Venom Cytotoxins, Phospholipase A2s, and Zn2+-dependent Metalloproteinases: Mechanisms of Action and Pharmacological Relevance.

Authors:  Sardar E Gasanov; Ruben K Dagda; Eppie D Rael
Journal:  J Clin Toxicol       Date:  2014-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.